Navigation Links
Globus Medical's MicroFuse(TM) Technology Engineered for Optimal Strength and Porosity
Date:3/25/2009

AUDUBON, Pa., March 25 /PRNewswire/ -- Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, today announced the launch of MicroFuse(TM) ST Granules, a unique resorbable polymer bone void filler optimized for both strength and porosity. MicroFuse(TM) technology utilizes proprietary combinations of poly (lactic acid) and poly (lactide-co-glycolide) polymers manufactured with a patented microsphere process to deliver up to twelve times the strength and twice the ideal porosity ratio of competing synthetic bone void fillers.

MicroFuse(TM)'s strength is derived from its unique three-dimensional structure which translates into better intra-operating handling characteristics. Due to its bonded sphere structure, MicroFuse(TM) is less likely to break apart while mixing with bone graft and during impaction at the bone defect site. MicroFuse(TM)'s structure is also designed to maximize the amount of pores in the optimal range for bone formation. Over 88 percent of MicroFuse(TM) pores are in this ideal range while most porous ceramics have many pores that are too small to allow for bone in-growth or are too large, which can slow the bone regeneration process.

"MicroFuse(TM) technology represents a unique entry into the synthetic bone substitute market. With an optimal combination of strength and porosity, MicroFuse(TM) is specifically engineered to resorb and be fully replaced by bone," said Mark Borden, Ph.D., Director of Biomaterials, Globus Medical, Inc. "From the choice of resorbable polymers to the size of the individual microspheres, developmental efforts were focused on providing the best possible environment for bone growth."

MILDER(TM)-the Natural Evolution of Spine Care

The MicroFuse(TM) ST Granules are the product of a significant development effort by Globus, and represent the latest addition to Globus Medical's MILDER(TM) Spine Care portf
'/>"/>

SOURCE Globus Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Globus Medicals SIGNATURE(TM) Spacer Designed for MILDER(TM) TLIF Procedures
2. Globus Medical Strengthens Executive Team with Appointment of CFO
3. Globus Medical Launches NIKO(TM) Corpectomy Spacer System
4. Globus Medical Announces Record Revenue for 2007
5. Hooper Holmes Concludes Sale of Medicals Direct
6. Council for American Medical Innovation Applauds President Obama for Calling for Serious Investments in Science and Technology
7. OBS Medicals Visensia Patient Monitoring Technology Lowers Cost of Medical Malpractice Insurance
8. CareTech Solutions Launches Robust Service Desk Solution to Support Clinical Applications and Technology within Continuum Health Partners Hospitals
9. Top Neurology Programs Control Fever with Arctic Sun Cooling Technology
10. BioHorizons Announces Its 2009 Global Symposium: Bringing Together Top Thought Leaders in the Dental Implant Industry to Provide Insight on Integrating Technology into the Continuum of Care
11. Sentinelle Medical Receives Frost & Sullivan Excellence in Technology Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... OR (PRWEB) March 06, 2015 Ticket Down ... in Portland, Oregon at the Moda Center. After ... superstar Garth Brooks is showing no signs of letting up ... the country legend and his wife, Trisha Yearwood, to venues ... would be bringing their critically acclaimed tour to the Moda ...
(Date:3/6/2015)... March 06, 2015 Ticket Down is a ... popular ticket exchange has extended their customer appreciation discount code ... Bridge, West Yorkshire England and he began his career in ... the past couple of years Ed Sheeran has become a ... Sheeran is on stage he is having the time of ...
(Date:3/6/2015)... At Natural Products Expo West, Makeena, ... of its powerful, location-aware iOS app that helps ... at any retailer that carries those products, including ... Booth 6054. , Makeena’s proprietary algorithm allows ... Paleo, and vegan, among many other product attributes. ...
(Date:3/6/2015)... Many patients with knee osteoarthritis have continued ... (or someone you know) have chronic pain and problems ... interested in the ACT-OA clinical trial. , Kevin ... is one of fifteen physicians in the U.S. to ... as part of a new, multi-site, double blind, placebo-controlled ...
(Date:3/6/2015)... Raleigh, NC (PRWEB) March 06, 2015 In ... percentage of Polish mesothelioma patients reported that shoulder pain was ... full story on its website. Click here to read ... in Warsaw analyzed the medical records of 49 mesothelioma ... of them reported that it was shoulder pain that first ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3Health News:Kevin Darr, M.D. is Now Enrolling Patients in a New FDA-Approved Clinical Trial Evaluating Adipose-Derived Regenerative Cells in the Treatment of Knee Osteoarthritis 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2
... In a study, U.S. researchers have found an increase in the ... the last 50 years//. Girls lose their virginity at the age ... to 15 for which the reasons may be less guilt about ... ,The study done by Jean Twenge, associate professor in psychology at ...
... recent survey it was found that people who were in ... look//. This resulted in an increase in the rates of ... in creating awareness among the procedures used in these surgeries. ... in the number of men and women in their sixties ...
... hundreds of people suffering from gastroenteritis have been admitted in ... reported Monday. ,At least three children have died of ... deaths were reported from southern Punjab, as temperatures shot up ... Dera Ghazi Khan and Bahawalpur. ,More than 150 ...
... over 4,000 people dying in road traffic accidents in the ... senior Delhi Police official. , ,"This city has a ... difficult to control and coordinate the traffic if the standard ... joint commissioner, traffic, said. ,He also said that about ...
... colleges in Delhi went on mass casual leave ... but compounding// the sufferings of patients. ,The ... College (MAMC), University College of Medical Sciences (UCMS) ... express their resentment against the government decision to ...
... 3 years woke up after being administered a sleeping pill, ... hit the research table for thorough clinical testing. , ... tested on 30 patients during the course of this year, ... of coma. After the initial success, the pill has been ...
Cached Medicine News:Health News:Road Traffic Accidents Kill 4,000 people in Delhi 2Health News:Mass Leave By Doctors Leaves Patients Helpless 2
(Date:3/5/2015)... und TÜBINGEN, Deutschland, 5. März 2015 /PRNewswire/ ... und das deutsche biopharmazeutische Unternehmen CureVac geben ... Euro (52 Millionen US-Dollar) in CureVac investiert. ... medizinisch angewandten Messenger-RNA (mRNA). Auf Basis dieses ... Behandlung von Krankheiten und zum Schutz vor ...
(Date:3/5/2015)... 2015  BioPhotas, Inc., an FDA registered medical device ... technologies to treat skin, muscle and joint conditions, today ... Fund to provide BioPhotas, flagship product, the Celluma, ... solutions.  Commenting on the alliance, ... the Celluma at the Warrior Hope and Care Center ...
(Date:3/5/2015)... -- Sanomedics, Inc. (OTC: SIMH, SIMHD) ("Sanomedics" or the "Company"), ... and acquiring cutting-edge technology, products and services announced today ... at booth # 709 at the National Association ... on March 11-13, 2015 at Caesars Palace in ... The 36 th annual NAPNAP Conference will bring ...
Breaking Medicine Technology:Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3
... April 8, 2011 ImageXpres Corporation (Pink Sheets: ... financial results and annual report that highlighted the key ... 31, 2010. Overall financial results for 2010 demonstrated significant ... and net income of $109,033 for all of 2010, ...
... 8, 2011 Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ... of drugs for the treatment of human viral diseases, today ... 18,310,000 shares of its common stock at a public offering ... being sold by Idenix. The offering is expected to close ...
Cached Medicine Technology:ImageXpres Posts OTC Markets 2010 Annual Report 2ImageXpres Posts OTC Markets 2010 Annual Report 3Idenix Pharmaceuticals Prices Public Offering of Common Stock 2
Poly stat Strep A is a lateral flow, one-step immunoassay for the rapid, qualitative detection of Group A Streptococcal antigen from throat swabs. The test is intended for use as an aid in the diagn...
... The CoaguChek S System offers ... in just one minute requiring only ... enable you to provide more comprehensive ... with each patient. The CoaguChek S ...
The QuickScreen Pro Multi Drug Screening Test is a rapid, self-timing, qualitative immunoassay for,the detection of drugs of abuse in urine....
The Osteomark NTx Point of Care (POC)device allows physicians to monitor their patients response to anti-resorptive drugs as early as 3-6 months from starting treatment. Osteomark NTx shows you and y...
Medicine Products: